Skip to main content
SpringerLink
Log in

Eingeladener Kommentar: Transplantevaluation und Therapie mit Prostaglandin E1 bei Patienten mit erhöhtem Lungengefäßwiderstand

  • Originalarbeiten
  • Published:
Acta Chirurgica Austriaca Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Müller H, Iberer F, Wasler A, Auer T, Petutschnigg B, Tscheliessnigg KH: Transplantevaluation und Therapie mit Prostaglandin E1 bei Patienten mit erhöhtem Lungengefäßwiderstand. Acta Chir Austriaca 1993;25: 358–361.

    Google Scholar 

  2. Kishor D, Popat MB, Pitt D: Hemodynamic effects of prostaglandin E1 infusion in patients with acute myocardial infarction and left ventricular failure. Am Heart J 1982;103:485–489.

    Article  Google Scholar 

  3. Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G: Comparison of Enalapril with Hydralazine—Isosorbide Dinitrate in the treatment of Chronic Congestive Heart Failure. N Engl J Med 1991;325:303–310.

    Article  PubMed  CAS  Google Scholar 

  4. The SOLVD Investigators: Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fraction and Congestive Heart Failure. N Engl J Med 1991;324:293–302.

    Google Scholar 

  5. Stevenson LW, Dracup, KA, Tillisch JH: Efficacy of Medical Therapy Tailored for Severe Congestive Heart Failure in Patients Transferred for Urgent Cardiac Transplantation. Am J Cardiol 1989;63:461–464.

    Article  PubMed  CAS  Google Scholar 

  6. Fonarow GC, Chelimsky-Fallick C, Stevenson LW, Luj M, Hamilton MA, Moriguchi JD, Tillisch JH, Creaser JA, Albanese E: Effect of Direct Vasodilation vs Angiotensin-converting-enzyme Inhibition on Mortality in Advanced Heart Failure: The Hy-C Trial. J Am Coll Cardiol 1992;19:842–850.

    Article  PubMed  CAS  Google Scholar 

  7. Pacher R, Globits S, Pacher B: Different Hemodynamic Effect of Prostaglandin E1 and Nitroglycerine in Chronic Heart Failure. J Heart Failure 1993;1:263 (abstr suppl).

    Article  Google Scholar 

  8. Pacher R, Wutte M, Rödler S, Globits S, Weber H: Additional Hemodynamic Benefit of Prostaglandin E1 Infusion in Catecholamine Dependent Heart Failure. J Heart Failure 1993;1:1155 (abstr suppl).

    Google Scholar 

  9. Bacher R, Globits S, Ogris E, Sochor H, Glogar D: Prostaglandin E1 verbessert die Hämodynamik bei fortgeschrittener Herzinsuffizienz und senkt erhöhte Plasma ANP Spiegel. Intensivmed Notfallmed 1990; 27:374.

    Google Scholar 

  10. Vincent JL, Carlier E, Pinsky, MR, Goldstein J, Naeje R, Lejcune P, Brimioulle S, Leclere JL, Kahn RJ, Primo G: Prostaglandin E1 infusion for right ventricular failure after cardiac transplantation. J Thorac Cardiovasc Surg 1992;103:33–39.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinischen Abteilung für Kardiologie der Universitätsklinik für Innere Medizin II, Währinger Gürtel 18-20, A-1090, Wien

    R. Pacher

Authors
  1. R. Pacher
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pacher, R. Eingeladener Kommentar: Transplantevaluation und Therapie mit Prostaglandin E1 bei Patienten mit erhöhtem Lungengefäßwiderstand. Acta Chir Austriaca 25, 362–363 (1993). https://doi.org/10.1007/BF02602220

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02602220

Search

Navigation